Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

115,544 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.
Rai S, Kim WS, Ando K, Choi I, Izutsu K, Tsukamoto N, Yokoyama M, Tsukasaki K, Kuroda J, Ando J, Hidaka M, Koh Y, Shibayama H, Uchida T, Yang DH, Ishitsuka K, Ishizawa K, Kim JS, Lee HG, Minami H, Eom HS, Kurosawa M, Lee JH, Lee JS, Lee WS, Nagai H, Shindo T, Yoon DH, Yoshida S, Gillings M, Onogi H, Tobinai K. Rai S, et al. Among authors: kim js. Haematologica. 2022 Oct 6. doi: 10.3324/haematol.2022.280996. Online ahead of print. Haematologica. 2022. PMID: 36200417
An Asian multi-national, multi-institutional, retrospective study on image-guided brachytherapy in cervical adenocarcinoma and adenosquamous carcinoma.
Okonogi N, Murakami N, Ando K, Murata M, Murata K, Aoshika T, Kato S, Saito AI, Kim JY, Yoshioka Y, Sekii S, Tsujino K, Lowanichkiattikul C, Pattaranutaporn P, Kaneyasu Y, Nakagawa T, Watanabe M, Uno T, Umezawa R, Jingu K, Kanemoto A, Wakatsuki M, Shirai K, Igaki H, Ohno T, Itami J. Okonogi N, et al. Among authors: kim jy. J Contemp Brachytherapy. 2022 Aug;14(4):311-320. doi: 10.5114/jcb.2022.119451. Epub 2022 Aug 31. J Contemp Brachytherapy. 2022. PMID: 36199951 Free PMC article.
115,544 results
You have reached the last available page of results. Please see the User Guide for more information.